In GBA1-PD patient-derived macrophages, these PCs increased GCase protein levels, enhanced GCase activity, and reduced GluCer and GluSph substrate accumulation; in patient-derived dopaminergic neurons, they also lowered α-synuclein levels (50, –52). Here, GBA1 is linked to Parkinson disease.